Postpartum depression (PPD) is a serious but treatable condition that can affect mothers after childbirth. While it’s common to experience short-term mood changes (known as “baby blues”), postpartum depression is more intense and longer-lasting. For many, postpartum depression medication may be necessary. Here’s everything you need to know about PPD medication, including the types, whether it’s safe for breastfeeding moms, and insurance coverage.
What is Postpartum Depression?
Postpartum depression is a mental health condition that can develop any time after giving birth, though it often starts within the first three weeks. Unlike the temporary lows that many new parents experience, PPD causes symptoms that interfere with everyday life and caregiving.
According to the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition, Text Revision (DSM-5-TR), postpartum depression now falls under the category of perinatal depression, which includes depressive episodes during pregnancy as well.
Symptoms of Postpartum Depression
Symptoms of postpartum depression can vary from person to person, but common ones include:
- Ongoing sadness, frequent crying, or emotional numbness
- Difficulty bonding with the baby
- Low self-esteem or feelings of failure as a parent
- Changes in appetite or sleep patterns
- Irritability or hostility, even toward the baby
- Anxiety, panic, or overwhelming worry
- Fatigue or a sense of disconnection from reality
- Hopelessness, guilt, or thoughts of self-harm
If these symptoms last for more than two weeks or make it difficult to care for yourself or your child, it’s important to reach out for professional help. It’s also worth mentioning that many individuals may mask their symptoms or downplay their distress out of shame or fear of judgment as there’s still a stigma around not feeling immediately bonded or happy after childbirth.
Types of Medication Used for Postpartum Depression
Medication is a large part of treatment, especially for moderate to severe PPD. For those who had depression before or during pregnancy, continuing or restarting medication after birth can reduce the risk of relapse. In fact, research shows that those who discontinue antidepressants are three times more likely to experience a recurrence compared to those who continue treatment.
Your doctor will help you determine which medication offers the most benefit with the least risk by looking at your symptoms, prior treatment history, and whether or not you plan to breastfeed. Your treatment plan may also include therapy, support groups, or lifestyle changes to go alongside medication.
SSRIs
Selective serotonin reuptake inhibitors (SSRIs) are the most commonly prescribed antidepressants for PPD. These include:
- Fluoxetine (Prozac)
- Paroxetine (Paxil)
- Sertraline (Zoloft)
- Citalopram (Celexa)
SSRIs are preferred due to their tolerability, effectiveness, and lower risk of side effects compared to older antidepressants. Studies show that postnatal SSRI treatment not only reduces depressive symptoms in the parent but may also positively affect relationship satisfaction and child development outcomes in early life.
SNRIs
Serotonin-norepinephrine reuptake inhibitors (SNRIs) are another first-line option when SSRIs are ineffective or not well-tolerated. These include medications like venlafaxine (Effexor XR) and desvenlafaxine (Pristiq).
Although clinical trials for SNRIs in postpartum populations are limited, open-label studies have shown SNRIs to relieve depression symptoms. These medications are considered in cases of comorbid anxiety as well.
FDA-Approved Postpartum Depression Medication
In addition to traditional antidepressants, the FDA has approved two medications specifically for postpartum depression: brexanolone (Zulresso) and zuranolone (Zurzuvae). Brexanolone is administered as a 60-hour continuous intravenous infusion in a hospital. In clinical trials, patients experienced rapid remission of symptoms within 24 hours, with sustained improvements over time. While effective, its delivery method and cost can make access limited.
Approved in 2023, zuranolone is the first oral medication developed to treat postpartum depression. It is taken over a course of two weeks and works by targeting GABA-A receptors in the brain. Clinical studies show significant improvement in depression symptoms compared to placebo, and these effects were sustained for at least four weeks after the final dose. Zuranolone is currently more accessible than brexanolone due to its ease of use and broader insurance coverage.
Is Postpartum Depression Medication Safe While Breastfeeding?
Many people worry about how antidepressants may affect breastfeeding. While some medications do pass into breast milk, the most common antidepressants for postpartum depression are considered safe and have not been shown to negatively impact infant development or milk supply.
The CDC recommends providers consider breastfeeding status when prescribing medications and adjust medications accordingly. It’s important to have an open conversation with your provider about your feeding preferences. In many cases, treatment and breastfeeding can safely go together, but if there are concerns, alternatives like formula-feeding or pumping schedules can be considered.
Does Insurance Cover Postpartum Depression Medication?
Yes, in most cases, insurance plans cover medications for postpartum depression. This includes traditional antidepressants and newer medications like Zurzuvae.
Major insurance providers such as UnitedHealthcare, Aetna (CVS), Kaiser Permanente, Anthem, HCSC, and Centene have added Zurzuvae to their formularies or pharmacy benefit plans. Additionally, most state Medicaid programs now cover Zurzuvae without excessive restrictions.
Patients may still need prior authorization, so it’s important to work with your healthcare provider as you work with your insurance company to get approval. Some pharmaceutical companies also offer patient assistant programs for those who are uninsured or underinsured.
Get the Support You Need at Cura Behavioral Health
Postpartum depression can be a challenging experience, but it is highly treatable with the several medications available, including newer drugs specifically for PPD. Whether you’re going through depression for the first time or have a history of mental health conditions, the right treatment can make a big difference.
At Cura Behavioral Health, we provide evidence-based care that’s personalized to each person’s needs, including medication management, therapy, and support for new parents. Contact us today to learn more about your treatment options.
Sources:
- Perinatal Depression – StatPearls
- Antidepressant Use While Breastfeeding: What should I know? – Infant Risk Center
- Postnatal SSRI treatment could benefit both mother and child – American Pharmacists Association
- Pharmacotherapy of Postpartum Depression: Current Approaches and Novel Drug Development – CNS Drugs
- Brexanolone to Treat Postpartum Depression in Adult Women – Psychopharmacology Bulletin
- Zuranolone for the Treatment of Postpartum Depression – The American College of Obstetricians and Gynecologists
- Postpartum Depression – CDC
- One Year Later: How Insurers Are Covering Zurzuvae, the First Postpartum Depression Pill – Policy Center for Maternal Mental Health
